Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Macerich Company (MAC)

Macerich Company (MAC)
13.96 -0.72 (-4.90%) 15:21 ET [NYSE]
13.90 x 100 13.97 x 1
Realtime by (Cboe BZX)
13.90 x 100 13.97 x 1
Realtime - - (-) -
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
13.86
Day High
14.51
Open 14.38
Previous Close 14.68 14.68
Volume 795,023 795,023
Avg Vol 2,529,990 2,529,990
Stochastic %K 35.71% 35.71%
Weighted Alpha -21.75 -21.75
5-Day Change +0.01 (+0.07%) +0.01 (+0.07%)
52-Week Range 12.48 - 22.27 12.48 - 22.27
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,706,656
  • Shares Outstanding, K 252,497
  • Annual Sales, $ 918,200 K
  • Annual Income, $ -194,120 K
  • EBIT $ 460 M
  • EBITDA $ 791 M
  • 60-Month Beta 2.17
  • Price/Sales 3.92
  • Price/Cash Flow 25.84
  • Price/Book 1.25

Options Overview Details

View History
  • Implied Volatility 58.98% ( +7.02%)
  • Historical Volatility 69.73%
  • IV Percentile 98%
  • IV Rank 57.69%
  • IV High 83.72% on 04/08/25
  • IV Low 25.26% on 12/09/24
  • Put/Call Vol Ratio 0.37
  • Today's Volume 70
  • Volume Avg (30-Day) 719
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 9,000
  • Open Int (30-Day) 10,628

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.31
  • Number of Estimates 8
  • High Estimate 0.33
  • Low Estimate 0.30
  • Prior Year 0.31
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.48 +11.62%
on 04/09/25
Period Open: 17.21
17.94 -22.35%
on 04/02/25
-3.28 (-19.06%)
since 03/21/25
3-Month
12.48 +11.62%
on 04/09/25
Period Open: 20.19
21.12 -34.04%
on 01/30/25
-6.26 (-31.01%)
since 01/21/25
52-Week
12.48 +11.62%
on 04/09/25
Period Open: 15.29
22.27 -37.45%
on 12/09/24
-1.36 (-8.89%)
since 04/19/24

Most Recent Stories

More News
Macerich and PenFed Credit Union Secure Exclusive Sponsorship Agreement for Tysons Corner Center Plaza

MAC : 13.96 (-4.90%)
Macerich Advances HiFi, Outdoor Mixed-Use Development at FlatIron Crossing in Colorado, Names Entertainment Anchor

MAC : 13.96 (-4.90%)
Macerich (MAC) Q4 2024 Earnings Call Transcript

MAC earnings call for the period ending December 31, 2024.

MAC : 13.96 (-4.90%)
Macerich: Q4 Earnings Snapshot

Macerich: Q4 Earnings Snapshot

MAC : 13.96 (-4.90%)
Macerich Reports Fourth Quarter 2024 Results

MAC : 13.96 (-4.90%)
Macerich To Present at Citi’s 2025 30th Annual Global Property CEO Conference

MAC : 13.96 (-4.90%)
Macerich Declares the Quarterly Dividend on Its Common Shares

MAC : 13.96 (-4.90%)
Macerich Schedules Fourth Quarter 2024 Earnings Release and Conference Call

MAC : 13.96 (-4.90%)
Macerich Announces Appointment of Devin Murphy to Board of Directors

MAC : 13.96 (-4.90%)
Macerich Announces Tax Treatment Of 2024 Dividends

MAC : 13.96 (-4.90%)
The Macerich Company Announces Underwritten Public Offering of 18 Million Shares of Common Stock

Macerich announces an 18 million share public offering to repay a mortgage loan and invest in short-term deposits.Quiver AI SummaryThe Macerich Company has announced it is launching a public offering of...

MAC : 13.96 (-4.90%)
Macerich Announces Pricing of Upsized Public Offering of Common Stock

MAC : 13.96 (-4.90%)
Macerich Announces Commencement of Public Offering of Common Stock

MAC : 13.96 (-4.90%)
Macerich (MAC) Q3 2024 Earnings Call Transcript

MAC earnings call for the period ending September 30, 2024.

MAC : 13.96 (-4.90%)
Macerich: Q3 Earnings Snapshot

Macerich: Q3 Earnings Snapshot

MAC : 13.96 (-4.90%)
Macerich Reports Third Quarter 2024 Results

MAC : 13.96 (-4.90%)
The Macerich Company Announces CFO Change

MAC : 13.96 (-4.90%)
GRESB Real Estate Assessment Ranks Macerich #1, U.S. Retail, for 10th Consecutive Year

MAC : 13.96 (-4.90%)
Macerich Declares the Quarterly Dividend on Its Common Shares

MAC : 13.96 (-4.90%)
Macerich Refinances Top-Performing Queens Center at Favorable Terms

MAC : 13.96 (-4.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

The Macerich Company is a retail real estate investment trust (REIT) that owns, acquires, leases, manages, develops, and redevelops regional and community shopping centers in high barrier-to-entry markets. Macerich primarily focuses on the attractive, densely populated markets of the United States. It...

See More

Key Turning Points

3rd Resistance Point 15.49
2nd Resistance Point 15.18
1st Resistance Point 14.93
Last Price 13.96
1st Support Level 14.37
2nd Support Level 14.06
3rd Support Level 13.81

See More

52-Week High 22.27
Fibonacci 61.8% 18.53
Fibonacci 50% 17.38
Fibonacci 38.2% 16.22
Last Price 13.96
52-Week Low 12.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.